- Home
- GNPX vs ABTS Comparison
GNPX vs ABTS Comparison
Compare GNPX & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- ABTS
- Stock Information
- Founded
- GNPX 2009
- ABTS 2010
- Country
- GNPX United States
- ABTS Hong Kong
- Employees
- GNPX N/A
- ABTS N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- GNPX Health Care
- ABTS Technology
- Exchange
- GNPX Nasdaq
- ABTS Nasdaq
- Market Cap
- GNPX 10.8M
- ABTS 8.9M
- IPO Year
- GNPX 2018
- ABTS N/A
- Fundamental
- Price
- GNPX $6.64
- ABTS $6.70
- Analyst Decision
- GNPX
- ABTS
- Analyst Count
- GNPX 0
- ABTS 0
- Target Price
- GNPX N/A
- ABTS N/A
- AVG Volume (30 Days)
- GNPX 1.7M
- ABTS 81.9K
- Earning Date
- GNPX 11-14-2025
- ABTS 08-13-2025
- Dividend Yield
- GNPX N/A
- ABTS N/A
- EPS Growth
- GNPX N/A
- ABTS N/A
- EPS
- GNPX N/A
- ABTS N/A
- Revenue
- GNPX N/A
- ABTS $7,037,156.00
- Revenue This Year
- GNPX N/A
- ABTS N/A
- Revenue Next Year
- GNPX N/A
- ABTS N/A
- P/E Ratio
- GNPX N/A
- ABTS N/A
- Revenue Growth
- GNPX N/A
- ABTS 31.69
- 52 Week Low
- GNPX $6.51
- ABTS $1.35
- 52 Week High
- GNPX $140.00
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- GNPX 63.07
- ABTS 45.39
- Support Level
- GNPX $7.71
- ABTS $6.00
- Resistance Level
- GNPX $9.89
- ABTS $9.03
- Average True Range (ATR)
- GNPX 1.15
- ABTS 1.03
- MACD
- GNPX 0.53
- ABTS -0.13
- Stochastic Oscillator
- GNPX 50.54
- ABTS 27.19
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.